Wereport a patient with ulcerative colitis complicated with idiopatic interstitial pneumonia, in whomthe etiology of interstitial pneumonia was unknown, but immunological disturbance might have been involved. There are many complications with ulcerative colitis, but interstitial pneumonia is quite rare and its prognosis is quite poor. Antibiotic and steroid treatment were given under respiration supported therapy, but no response could be obtained. In the treatment of patients with ulcerative colitis, we must be mindful of interstitial pneumonia because the prognosis is quite poor. (Internal Medicine 40: 883-886, 2001) 
Introduction
Ulcerative colitis (UC) can be associated with a variety of extraintestinal manifestations, but the lung is rarely involved. Bronchopulmonarydisease in patients with UChas sometimes been considered as an adverse reaction to sulfasalazine (SASP) therapy. Wereport a non-smoker UCpatient with interstitial pneumonia, in whoma trans bronchial lung biopsy was performed and the causal relationship between drug and pulmonary manifestations could not be established.
Case Report
A 55-year-old man suffered from UCfrom the age of 35. At the age of 35, maintenance therapy was begun with oral SASP and prednisolone, with resolution of symptoms. He had never smokedand had no history of allergic or respiratory disease. In December 1998, he developed bloody diarrhea, abdominal pain and was admitted to our hospital at the end of that month. Endoscopic examination on the 8th day after admission showed diffuse erosions and ulcers in the rectum, sigmoid, descending and transverse colon (Fig. 1) . Barium enema study on the 30th day after admission showed barium flecks in the descending and transverse colon with lead pipe appearance (Fig. 2) , and bariumflecks were also observedin the rectum and sigmoid colon. After admission treatment was started with intensive regimen therapy (prednisolone, 50 mg) and SASP was discontinued because aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were elevated (AST 49 U//, ALT132 U//); on the 16th day after admission, we suspected drug-induced liver function disorders. The response to the intensive regimen therapy was not satisfactory, diarrhea with blood was being passed 5 or 6 times a day. So leucocytapheresis therapy with a leucocyte removal filter was started on February 10, 1999. That therapy was performed once a week, 7 times in total, until April 7, 1999 with prednisolone therapy. But the response to that therapy was not satisfactory, either. Heabruptly developed a high fever (38.5°C) on April 10, 1998, and other respiratory symptomssuch as cough were not observed before the fever rose. The chest roentgenogramrevealed a reticular shadow in the lower lobe of the left lung (Fig. 3) . The shadow spread rapidly over almost the entire lung (Fig. 4) . Chest computed tomographic (CT) films showed parenchymatous shadow over most of the lung field, with small regions of reticular shadows (Fig. 5) . Eosinophilia was not found in peripheral blood. An arterial blood sample showed severe hypoxia (PO2, 36.6 torr, PCO2, 32.6 torr) on April 23, 1999. Intra-trachial intubation was performed and mechanical ventilation was started. Klebsiella pneumoniawas found in the culture of sputum on April 21 , 1999 . Wemade the diagnosis of bacterial pneumonia complicated with interstitial pneumonia. Wetreated him with antibiotics and steroid pulse therapy (methyl prednisolone 1,500 mg/day x3). The pneumonia caused by cytomegalovirus or pneumocystis carinii shows an interstitial shadow. In this case, anti-cytomegalovirus IgMwas negative.
Transbronchial lung biopsy was performed on May ll, 1999.
The specimen showed that the majority of the lung parenchyma had been replaced by fibrous tissue, accompanied by a moderate infiltration of lymphocytes (Fig. 6) . In this specimen, there wasno cytomegalovirusnuclear or cytoplasmicinclusions, nor was there any foamy, amorphous material composed of proliferating protozoas and cell debris, typically observed in
Pneumocystis carinii pneumonia, in the alveolar spaces. We (8, 9) , both interstitial pulmonary disease and ulcerative colitis have been associated with circulating immunecomplexes (10) (11) (12) (13) , and altered effector-cell function has been described in both disorders (14) (15) (16) . One hypothesis concerning the pathophysiology of idiopathic interstitial pneumonia includes a stimulus active on the cell surface, perhaps immunecomplexes, lymphocytesand macrophageactivation and cytokine release (10, 14, 17) . Cytokines, such as macrophage growth factor, platelet-derived growth, and/or fibronectin, may then stimulate mesenchymal cells, such as fibroblasts, to proliferate and synthesize and release collagen into the pulmonary interstitium (18) (19) (20) . In the majority of these cases steroids were very effective (7), because they inhibit the production of some cytokines and also inhibit cellular effects by reducing receptor binding or expression (21, 22) . But in several patients with severe airway inflammation or chronic bronchiolitis, steroids lacked effectiveness (7) . Wetreated the patient with a high dose of steroids several times as pulse therapy, but the response was not satisfactory. Leukocytapheresisexerts an immunosupressive or immunomodulating effect in patients with UC (23), so it is hard to say that this therapy is connected with interstitial pneumonia. Nosevere adverse effect wasobserved in this therapy (24) , such as infection. However, steroids have an immunosupressive effect, and patients treated with them for a long time sometimes suffer from opportunistic infections. In this patient, bacterial pneumonia complicated with interstitial pneumonia Internal Medicine Vol. 40, No. 9 (September 2001) deteriorated the condition. Interstitial pneumonia is quite a rare complication of ulcerative colitis, but the prognosis is quite poor. Wemust be mindful of this complication.
